HBV QsAG is Ready for Prime Time
HCC Surveillance in an Era of Biomarkers
Physicians Update June-July 2015
Hepatitis C and B medicines added to WHO Model List of Essential Medicines
Hepatic Encephalopathy
Treatment Options for Liver Cancer
The Pruritus Sheet
European Association for the Study of the Liver (EASL) Poster
Treatment Options for Liver Cancer (Audio Recording)
A Name Change for Primary Biliary Cirrhosis (PBC): Cholangitis Replacing Cirrhosis
Treatment Options for Liver Cancer: What You Need To Know
Increasing Knowledge of Molecular Pathways In Hepatocellular Carcinoma
Liver Biopsy versus Non-Invasive Tests of Fibrosis
Template Letter for Insurance Mandating 8 Weeks vs 12 Weeks of Harvoni
Common Questions and Answers for Patients With or At Risk for Cirrhosis
Cirrhosis of the Liver: Handout and Information Sheet
HCC Surveillance
DRAFT 2016 Letter to Issuers in the Federally-facilitated Marketplaces
Stanford Liver Transplant and General Hepatology Outreach